Bio Integrates 2023 Track 2


Everything else that is important to success that’s not the science!

Fireside Chat

Fireside Chat

Camilla Easter | Chief Executive Officer | Oxford Medical Products

Vineeta Tripathi | Chief Executive Officer, Chief Scientific Officer | Vitarka Therapeutics

Lydia Mapstone | Chief Executive Officer and Co-founder | BoobyBiome

Interviewed by

Martino Picardo | Chairman | Discovery Park

Walking the antibody catwalk

Therapeutic antibody design and engineering – is this modality still relevant – is C&GT taking over, or is there a resurgence of small molecules?


Alan Boyd | CEO & Founder | Boyds


Marc Wilkinson | Partner, European and UK Patent Attorney | J A Kemp LLP

Jolyon Martin | Co-Founder and Head of Business Development | PetMedix

Adrian Kinkaid | Chief Executive Officer | Fusion Antibodies

Fiona Dempsey | Director of Scientific Operations | Medannex

Carolyn Flanigan | Director of Operations | Absolute Antibody

Growing in a time of drought

Getting investment to grow your business; fundraising in a tough environment


Jason Mellad | Chief Executive Officer | Start Codon


Tessa Pugh | Chief Executive Officer & Co-founder | PharmaReview

Jenny Button | Chief Executive Officer | Emm

Tina Flatau | Chief Business Officer | Sixfold Bioscience

Jo Derbyshire | Director of Grants and Tenders | Inventya Group

Michal Barski | Chief Executive Officer | Reciprocal Space

Tick tock, tick tock …

Scaling up – I’ve got my investment, now how do I deliver the next milestones quickly? Including team, manufacturing, capacity & making it happen.


Jenny Laird | Vice President, Search & Evaluation Pain & Neurodegeneration | Eli Lilly and Company


John von Benecke | Chief Executive Officer | Locate Bio

Nigel Brooks | Coach & Advisor​ | Lean Life Science

Will Brooks | Investment Director | Downing

Nick Smith | Regional Operationas Manager | Scitech

Craig Fox | Operating Partner Life Sciences | Oxford Science Enterprises

Managing your partners

Managing your CDMO and CRO partners to get the slots you need when you need them – does a small entity have any leverage?


Jo Craig | Senior Vice President CMC | NeRRe Therapeutics


Chris Davison | Chief Executive Officer | Custom Pharma Services

Roel de Nobel | General Manager & SVP Business Unit Solids | Aenova Group

Rabia Khan | Founder & Chief Executive Officer | Serna Bio

Andy Clarke | Managing Director and Country Manager | YSDS